University of Oxford

Faruk Bhagani Joins Element Blue's Healthcare Technology Practice

Retrieved on: 
Monday, March 20, 2023
University of Oxford, University, Growth, OPEN, Southern California, Salesforce, History, Management

HOUSTON, March 20, 2023 /PRNewswire-PRWeb/ -- Element Blue, a Houston-based healthcare technology consultancy and certified custom solution provider, announced that Faruk Bhagani has joined the firm as senior vice president, sales.

Key Points: 
  • HOUSTON, March 20, 2023 /PRNewswire-PRWeb/ -- Element Blue, a Houston-based healthcare technology consultancy and certified custom solution provider , announced that Faruk Bhagani has joined the firm as senior vice president, sales.
  • "We are pleased to welcome Faruk to Element Blue," said Steven Gerhardt, Managing Partner & CEO.
  • "His industry knowledge and experience in leading high-performing sales teams will benefit our clients and is integral to the continued growth of our intelligent automation healthcare practice."
  • "I look forward to contributing to its vision for the future as the healthcare sector further embraces innovative technology solutions."

Thomas W. Brown Appointed Chief Real Estate Officer of Yesway

Retrieved on: 
Monday, March 20, 2023
University, Moses Austin, Urban Land Institute, International Council, Shopping, University of Dallas, Business administration, Homemade Knives, United, National Association, International Council of Shopping Centers, Master of Business Administration, University of Oxford, Commercial property, Management

BEVERLY, Mass., March 20, 2023 /PRNewswire/ -- Brookwood Financial Partners, LLC ("Brookwood"), a nationally-recognized private equity real estate firm, is pleased to announce that Thomas W. Brown has been named the Chief Real Estate Officer of Yesway, the 435-store strong convenience store operator founded by the firm in 2015.

Key Points: 
  • BEVERLY, Mass., March 20, 2023 /PRNewswire/ -- Brookwood Financial Partners, LLC ("Brookwood"), a nationally-recognized private equity real estate firm, is pleased to announce that Thomas W. Brown has been named the Chief Real Estate Officer of Yesway, the 435-store strong convenience store operator founded by the firm in 2015.
  • He is extremely well respected by colleagues and clients in the private equity, commercial real estate, and convenience retailing realms for his astute knowledge and depth of experience," said Tom Trkla, Chairman and Chief Executive Officer of Brookwood, and Chairman, President, and Chief Executive Officer of Yesway.
  • In his capacity as Chief Real Estate Officer, Tom will be responsible for directing all real estate related activities for the firm, including identifying potential site and convenience store acquisitions, and overseeing the firm's store remodel, raze and rebuild, and new-to-market construction initiatives.
  • Mr. Brown also previously served as President of a publicly held national real estate firm where he was responsible for the real estate operations of 250 office buildings and shopping centers throughout the United States.

Aquavit Files Additional IND for DTX-024, a New Botulinum Toxin With Microchannel Technology™ for Palmar Hyperhidrosis

Retrieved on: 
Saturday, March 18, 2023
Neurotoxin, BA, Drug development, Columbia University Vagelos College of Physicians and Surgeons, University, Hyperhidrosis, Allergan, MBA, Uniform Securities Agent State Law Exam, Doctor of Philosophy, Aquavit, Harvard Medical School, Dermatology, Investment, Patient, Physician, Ophthalmology, FINRA, Axial, Drug discovery, Knowledge, Health, FDA, IND, Clostridium botulinum, Neurology, University of Oxford, Pharmaceutical industry, Management, MD

NEW YORK, March 18, 2023 /PRNewswire/ -- Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar hyperhidrosis using its patented microchannel technology™.

Key Points: 
  • NEW YORK, March 18, 2023 /PRNewswire/ -- Aquavit Holdings has submitted to FDA an IND for its DTX-024, for the treatment of palmar hyperhidrosis using its patented microchannel technology™.
  • Alongside Aquavit's biosimilar program for its botulinum toxin, this will be the first in the world, indicated for palmar hyperhidrosis, approved by FDA.
  • Aquavit has been investing in proprietary delivery technologies and related intellectual property for botulinum toxin.
  • This is a strategic move that puts them ahead of the curve in the fast-growing multi-billion-dollar botulinum toxin market.

CarbonMeta Technologies Inc. Discusses Significance of $6 Million Solar Power Project with The Stock Day Podcast

Retrieved on: 
Wednesday, March 8, 2023
Waste, Research, University of Oxford, COWI, Mining, Carbon, Environment, Plastic, Interview, OTC Markets Group, Hydrogen, Renewable energy

Jolly then commented on a recent announcement detailing the Company's securement of a $6 million solar power project.

Key Points: 
  • Jolly then commented on a recent announcement detailing the Company's securement of a $6 million solar power project.
  • "We had put together these EarthCrete® pavers, which are developed with waste materials from mining and construction products," said Spencer.
  • "We also had the ability to deliver the solar panels that they were looking for," said Spencer.
  • To close the interview, Spencer elaborated on the significance of the Company's $6 million solar contract, which will take place over one year.

Bright Data CEO Advises UK Politicians on Need for Industry-Led Public Web Data Regulation

Retrieved on: 
Tuesday, March 14, 2023
Data Management, Technology, Professional Services, Online Privacy, Other Technology, Data Analytics, Software, Artificial Intelligence, Public Policy, Government, Advocacy Group Opinion, Thought Leadership, Computer science, Ben Goertzel, University, UK Parliament Week, Research, Ernst & Young, University of Essex, All-Party Group for World Governance, UK Government Decontamination Service, Student, Ethics, Inquiry, Accenture, National Coding Week, University of Oxford, Government of the United Kingdom, Parliament of the United Kingdom, University of London, NDS, Electronic engineering, Russell Group, Lord Tim, Digital, Nursing, Tutoring

Or Lenchner, CEO of the industry-leading public web data platform Bright Data, last month joined members of the UK Parliament at a roundtable discussion looking at issues around ethics and regulation in data and alternative intelligence (AI).

Key Points: 
  • Or Lenchner, CEO of the industry-leading public web data platform Bright Data, last month joined members of the UK Parliament at a roundtable discussion looking at issues around ethics and regulation in data and alternative intelligence (AI).
  • He outlined how, as a responsible leader in the web data domain, Bright Data is taking steps to self-regulate and, hopefully, set ethical standards that point the way to effective regulation.
  • As one of the world’s biggest public web data platforms, Bright Data feels a sense of responsibility to help ensure that data is collected and used in the most ethical ways.
  • Participation in the Inquiry is a continuation of Bright Data’s support for the UK Government in implementing the National Data Strategy (NDS).

FinovateEurope to Host 35+ Live Demos Showcasing the Latest Fintech Solutions

Retrieved on: 
Monday, March 6, 2023
Citigroup, FS, HSBC, Barclays, JPMorgan Chase, University of Oxford, Research, Growth, Future of Humanity Institute, BNP Paribas, Name, Government, Informa, VCS, Fintech, Future, ING, Fidelity Investments, Management

LONDON, March 06, 2023 (GLOBE NEWSWIRE) -- via NetworkWire -- Informa PLC (“ Informa ”), a London-based events production, digital products and academic research services agency, will host FinovateEurope .

Key Points: 
  • LONDON, March 06, 2023 (GLOBE NEWSWIRE) -- via NetworkWire -- Informa PLC (“ Informa ”), a London-based events production, digital products and academic research services agency, will host FinovateEurope .
  • Finovate believes that the time of financial sector executives, investors, C-suite leaders, financial innovators, fintech operators and other attendees is invaluable.
  • 48% of past attendees are from financial institutions such as banks, credit unions and investment management firms, while 28% represent fintech or technology companies.
  • To view the list of speakers and the detailed agenda for both days, visit https://informaconnect.com/finovateeurope/agenda/1/
    To register for the in-person event, visit https://informaconnect.com/finovateeurope/purchase/select-package/

Aiberry Secures $8M in Seed Funding to Accelerate AI-Powered Mental Health Screenings

Retrieved on: 
Wednesday, March 8, 2023
Mental Health, Technology, Venture Capital, Health Technology, Telemedicine, Virtual Medicine, Professional Services, Software, General Health, Health, Artificial Intelligence, Linda, Newton, Depression, World Health Organization, Nervous, Diagnosis, Medical statistics, CCG, Brain, University of Oxford, Artificial intelligence, Research, School, Social, Suicidal ideation, Intelligence, Ascension, Patient, Mental health, Anxiety, Multimedia, Trust, National Center for Health Statistics, NCHS, Bias, VC, Mental, Organization, Georgetown University, National Center for Telehealth & Technology, Medical device, Nursing

Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI.

Key Points: 
  • Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) today announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI.
  • (Photo: Business Wire)
    Mental health issues are widespread and growing rapidly.
  • “AI platforms such as Aiberry provide a wide range of benefits compared to traditional diagnostic methods,” said Lynne Dunbrack, Group Vice President for IDC Health Insights.
  • This allows organizations to easily determine which mental health resource is the best investment for their specific needs and goals.

Biological Dynamics Appoints Zach Miller to Board of Directors

Retrieved on: 
Tuesday, March 7, 2023
Science, Biotechnology, Research, Surgery, Oncology, Health, Clinical Trials, Other Health, Slate, Tiger Global Management, Philosophy, Biological Dynamics of Forest Fragments Project, Bain Capital, Worcester College, Oxford, University of Oxford, Growth, Miller, Pancreatic cancer, Partnership, Patient, Williams College, Information technology, Biology, Pharmaceutical industry

Biological Dynamics, Inc. , an emerging growth life sciences company commercializing its ExoVerita™ platform for exosome-isolation and ExoVita™ Pancreas assay for the early detection of pancreatic cancer, has appointed Zach Miller as a member of its Board of Directors.

Key Points: 
  • Biological Dynamics, Inc. , an emerging growth life sciences company commercializing its ExoVerita™ platform for exosome-isolation and ExoVita™ Pancreas assay for the early detection of pancreatic cancer, has appointed Zach Miller as a member of its Board of Directors.
  • Miller will provide strategic guidance and direction for the Company as it enters a period of rapid growth and commercial operations.
  • Miller holds a bachelor’s degree, summa cum laude, from Williams College and a master’s degree in philosophy with distinction from Worcester College, Oxford University.
  • “I am honored to join Biological Dynamics’ Board of Directors and look forward to supporting the Company’s mission to provide groundbreaking diagnostic solutions for early disease detection,” Miller said.

BPGbio Announces Appointments to its Leadership Team to Accelerate Research and Commercialization

Retrieved on: 
Monday, March 6, 2023
Research, Technology, Infectious Diseases, Neurology, Biotechnology, Pharmaceutical, Health, Science, Oncology, Artificial Intelligence, Ethos, Innova, BMS, Service, Jawaharlal Nehru University, Credit Suisse, MBA, CSO, Thermo Fisher Scientific, Citigroup, Biogen, AstraZeneca, Engineering, Interrogative, University of Oxford, NCI, LATAM, Growth, Accounting, Celgene, USC, JPMorgan Chase, UCLA, National Cancer Institute, Biology, University of Cambridge, Lehigh University, Master of Science, Life Technologies, Innovation system, Investment, Bristol Myers Squibb, Harvard University, CFO, Translational medicine, Prudential Securities, Treasury, Master of Engineering, Pharmaceutical industry, Management, IIT Delhi, Genetics

Dr. Thakurta’s leadership and scientific contributions have led to six approved cancer drugs in multiple indications.

Key Points: 
  • Dr. Thakurta’s leadership and scientific contributions have led to six approved cancer drugs in multiple indications.
  • Prior to BPGbio, Dr. Thakurta was the Vice President, Translational Medicine at Bristol Myers Squibb where he oversaw the hematological malignancy group.
  • Before BMS, Dr. Thakurta served several leadership roles at Celgene, AstraZeneca and Biogen Idec and the United States National Cancer Institute (NCI) earlier in his career.
  • Prior to BPGbio he led strategy and investments for Innova Medical Group and was a Principal at Pasaca Capital.

London's Apollo Art Auctions to Host March 12 and 15 Sales of Expertly Curated Ancient and Cultural Art, Antiquities, Coins and Islamic Art

Retrieved on: 
Thursday, March 9, 2023
Online, Christie, Walters Art Museum, Artifact, Fifth Dynasty of Egypt, Metropolitan Museum of Art, Element, University of Oxford, Clothing, Sale, Christie's, Ottoman Empire, Islamic art, Collection, Ancient Egypt, University, Near East, Islam, Glass, Doctor of Philosophy, AD, Manuscript, Gold, Bookbinding, Auction, Book, Furniture

LONDON, March 9, 2023 /PRNewswire/ -- As any collector of fine objects would attest, you can never have too much of a good thing. London's premier source for exquisite ancient and cultural art, Apollo Art Auctions, agrees with that sentiment, which is why they've organized two separate and distinct gallery sales in mid-March to accommodate an abundance of recently consigned treasures.

Key Points: 
  • The first sale, on March 12, is a 553-lot offering titled Ancient Art, Antiquities & Coins.
  • Following closely on March 15 is a magnificent 339-lot selection of Islamic Art.
  • The opening session encompasses a broad range of art and artifacts from Classical Europe, Egypt and the Near East, India and China.
  • The catalogue is divided into sections specifically devoted to Classical and Egyptian antiquities; coins, medieval works of art, and Asian works of art.